Vantage BioTrials named “Canada’s Leading Clinical Research and Trial Management Organization”
MONTREAL, January 21, 2020 – Vantage BioTrials is a full-service Contract Research Organisation (CRO) offering clinical trial management services with operational capabilities across North America, Latin America and Europe. With the proficiency to navigate through many aspects of a client’s needs, from the various stages of clinical investigations (for drugs and medical devices), it’s a company that has the skill to handle whatever work is thrown its way.
Named as “Canada’s Leading Clinical Research and Trial Management Organization, 2020” by Aquisition International, Vantage BioTrials believes that success is achieved through shared values, common objectives and a high level of trust and transparency. These important values serves to support the ability to share risk and commit to a long-term relationship with it’s Sponsors & collaborators.
Vantage BioTrials continues to gain positive feedback not only from their Sponsors, but from Investigative Sites as well. A recent challenge for the company was the completion of a four-year-long Phase IV Post Market epidemiological clinical trial into a dermatological Rare Disease indication. This project had an anticipated patient enrollment target of 24 months from the client, but Vantage BioTrials was able to accelerate this by 12 months, allowing more patients to be included in the Sponsor’s statistical analysis. This is one of the major advantages of working with a smaller company like Vantage BioTrials, as opposed to one of the larger CROs, as a smaller firm can demonstrate more flexibility in its day to day operations.
Looking forward, Vantage BioTrials intends to collaborate further with patient groups in order to improve time-to-market, quality, reach and value for money. The company has already managed to connect with Colorectal Cancer Canada, and now in partnership with other patient groups, clinical research centres and industry stakeholders.
All involved groups are committed to improving the quality of cancer clinical trials and access to new treatments through the integration of patient partners.
The clinical trials industry is one with incredibly close links to global markets as well as significant R&D expenditure. Every economy has its slow points and ensuring that Vantage BioTrials is prepared with innovative strategies to match the slow periods is key. Keeping an eye on what customers want and anticipating not only their needs and expectations, but those of regulators, helps Vantage BioTrials to take advantage of its lean business model and agile nature to provide the flexibility of swift market turnarounds. It’s this lean model that helps each client achieve quick results.
When it comes to clinical trials, you can count on Vantage BioTrials’ trusted expertise to carry out high quality work, as quickly as possible and as efficiently as possible. Vantage BioTrials is not just a CRO focused on making the sale, but rather the need to ensure that everyone gets an equal amount of care and attention.
To read the full article by AI Magazine, click here.
Founded in 2007, Vantage BioTrials is a privately-held Contract Research Organization (CRO) that provides Phase I-IV clinical trial management services and implements Risk-Based Management through the use of Quality by Design (QbD) methodologies, all delivered to international pharmaceutical, biotechnology, generic pharmaceutical and medical device companies.